Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to examine the effects and safety of Korean red ginseng capsule and placebo with middle-aged and elderly sub-health population.


Clinical Trial Description

Processed red ginseng are non-toxic and healthy "tonics". It was recorded in medical books and Materia Medica that taking it for a long time can prolong life. The main purpose of this study is to evaluate the effect of ginseng on antioxidation and healthy aging indicators of sub-health subjects in Han Chinese population. Subjects will undergo a safety follow-up after the treatment period. Safety and efficacy will be determined by looking at a number of assessments [physical examinations, blood sampling, hearing sub-health status evaluation questionnaire (shsq-25), etc.]. It is expected that around 900 people (at least 450 in each arm) with sub-healthy state may take part in the study. The study participants will be recruited at around 3 sites from Shanghai, Beijing and Foshan, in China. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05592093
Study type Interventional
Source Shanghai Jiao Tong University School of Medicine
Contact Hongsheng Tan, Doctor
Phone 86-21-63846590
Email tanhs@shsmu.edu.cn
Status Recruiting
Phase Phase 2/Phase 3
Start date March 1, 2023
Completion date December 30, 2024